I agree that this site is using cookies. You can find further informations here.
X
Galli, Monica
512  results:
Search for persons X
?
1

Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:

Martino, Enrica Antonia ; Palmieri, Salvatore ; Galli, Monica...
Hematological Oncology.  42 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide..:

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. 165-176.e4 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A real‐world retrospective–prospective analysis of efficacy..:

Furlan, Anna ; Cea, Michele ; Pavan, Laura...
Cancer Medicine.  13 (2024)  7 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
4

Impact of minimal residual disease standardised assessment ..:

Zamagni, Elena ; Oliva, Stefania ; Gay, Francesca...
eClinicalMedicine.  60 (2023)  - p. 102017 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:

Gentile, Massimo ; Vigna, Ernesto ; Palmieri, Salvatore...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
6

P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARRO..:

D'agostino, Mattia ; Bruinink, Davine Hofste Op ; van Duin, Mark...
HemaSphere.  7 (2023)  S3 - p. e36094ab , 2023
Link: https://doi.org/10.1097/..
 
?
7

OA-44 Pomalidomide, bortezomib, and dexamethasone vs bortez..:

Beksac, Meral ; Richardson, Paul ; Oriol, Albert...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S27-S28 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P970: A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EF..:

Furlan, Anna ; Cea, Michele ; Zambello, Renato...
HemaSphere.  7 (2023)  S3 - p. e08128cd , 2023
Link: https://doi.org/10.1097/..
 
?
9

Genetic defects of gamma‐secretase genes in a multiple myel..:

Cattaneo, Irene ; Valgardsdottir, Rut ; Cavagna, Roberta...
British Journal of Haematology.  204 (2023)  2 - p. 571-575 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Elotuzumab plus lenalidomide and dexamethasone in relapsed/..:

Bruzzese, Antonella ; Derudas, Daniele ; Galli, Monica...
Hematological Oncology.  40 (2022)  4 - p. 704-715 , 2022
Link: https://doi.org/10.1002/..
 
?
11

Survival Risk Scores for Real-Life Relapsed/Refractory Mult..:

Morabito, Fortunato ; Zamagni, Elena ; Conticello, Concetta...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Lenalidomide-based triplet regimens in first relapsed multi..:

Mangiacavalli, Silvia ; Cartia, Claudio Salvatore ; Galli, Monica...
Haematologica.  108 (2022)  3 - p. 833-842 , 2022
Link: https://doi.org/10.3324/..
 
?
13

P-253: Impact of adjusting bortezomib dose in the pomalidom..:

Larocca, Alessandra ; Weisel, Katja ; Galli, Monica...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S175 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Pomalidomide, bortezomib, and dexamethasone at first relaps..:

Richardson, Paul G. ; Schjesvold, Fredrik ; Weisel, Katja...
European Journal of Haematology.  108 (2021)  1 - p. 73-83 , 2021
Link: https://doi.org/10.1111/..
 
?
15

OAB-055: Gain and amplification of 1q induce transcriptome ..:

D'Agostino, Mattia ; Belotti, Angelo ; Zamagni, Elena...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S34 , 2021
Link: https://doi.org/10.1016/..
 
1-15